# BIOFLOW III Asia Registry Orsiro Stent System

> **NCT01941290** · — · COMPLETED · sponsor: **BIOTRONIK Asia Pacific Pte Ltd** · enrollment: 387 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischemia
- Diabetes Mellitus Type 1 or 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01941290
- **Lead sponsor:** BIOTRONIK Asia Pacific Pte Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2017-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01941290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01941290, "BIOFLOW III Asia Registry Orsiro Stent System". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01941290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*